Provided by Tiger Trade Technology Pte. Ltd.

Medpace

595.41
+7.891.34%
Post-market: 595.410.00000.00%16:15 EDT
Volume:200.95K
Turnover:119.24M
Market Cap:16.62B
PE:34.91
High:600.93
Open:595.99
Low:589.44
Close:587.52
52wk High:677.90
52wk Low:373.00
Shares:27.91M
Float Shares:22.46M
Volume Ratio:1.12
T/O Rate:0.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):17.06
EPS(LYR):15.28
ROE:162.15%
ROA:20.10%
PB:38.30
PE(LYR):38.97

Loading ...

Nov 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 17, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 24, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 24, 2023

Major Issues Report

Form 8-K - Current report
Sep 22, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 21, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 19, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 31, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 27, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 25, 2023

Major Issues Report

Form 8-K - Current report
Jul 25, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 07, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2023

Major Issues Report

Form 8-K - Current report
Apr 25, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 25, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Major Issues Report

8-K - Current report